Entering text into the input field will update the search result below

Sanofi said to be considering bid for Actelion

Dec. 05, 2016 5:04 PM ETSanofi (SNY) StockJNJ, SNYBy: Douglas W. House, SA News Editor11 Comments
  • Bloomberg reports that Sanofi (NASDAQ:SNY) is mulling a bid for Actelion, potentially challenging Johnson & Johnson's (NYSE:JNJ) $250-a-share offer. If so, it will be pricey. Actelion is currently valued at ~$20B.

Recommended For You

About SNY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SNY--
Sanofi